Are Standard Dosing Regimens of Piperacillin-Tazobactam Suitable in Critically Ill Patients With Open Abdomen and Negative Pressure Wound Therapy? A Population Pharmacokinetic Study.

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

November 18, 2022

Study Completion Date

January 27, 2023

Conditions
LaparotomyCritical IllnessPiperacillin, Tazobactam Drug Combination
Interventions
PROCEDURE

Blood sampling (T0, inclusion)

Blood sample (5 ml) at 30 minutes after the loading dose of 4g/0.5g over 30 minutes for therapeutic drug monitoring at peak concentration (Cmax)

PROCEDURE

other samplings (T1)

"\- T1 : Day of the first surgical revision, under PTZ administered by continuous infusion : Blood sample (5 ml) for therapeutic drug monitoring at steady state concentration (Css).~Urinary sample and collection of urinary volume between T0 and T1 (Urinary Clearance) NPT fluid sample and collection of NPT volume between T0 and T1 (Peritoneal Clearance) Peritoneal sampling for therapeutic drug monitoring at the site of infection (CPt)"

Trial Locations (1)

Unknown

CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER